Skip to main content
. 2021 Feb 9;10(4):e017008. doi: 10.1161/JAHA.120.017008

Figure 6. Efficacy and safety of ticagrelor 60 mg vs placebo stratified by high (N=2714) or low (N=11 240) bleeding risk at baseline.

Figure 6

A sensitivity analysis of efficacy and safety was performed based on baseline bleeding risk, defined as the presence or absence of either a history of spontaneous bleeding requiring hospitalization before the randomization or anemia (defined as hemoglobin ≤13.5 g/dL for men and ≤12.0 g/dL for women). ARI indicates absolute risk increase; ARR, absolute risk difference; CV, cardiovascular; HR, hazard ratio; MI, myocardial infarction, ICH, intracranial hemorrhage; and TIMI, Thrombolysis in Myocardial Infarction.